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On the basis of the results of performed analysis of literature references concerning influence 
of phthalates on population health indicators it was found out that their influence at prenatal 
period may lead to asthma development in children, as well as to allergy, obesity; they also 
provide anti-androgens effect, leading to growth inhibition and delay in sexual maturation, 
and to variance of systolic pressure. In case of men phthalates are associated with decreasing 
of testosterone level and sperms quality, that indicates at their possible role in male sterility. In 
case of women phthalates are associated with increase of the risk of the second type of diabetes 
appearance, as well as leiomyoma, endometriosis and breast carcinoma. Laboratory studies 
performed in accordance with Customs union’s technical regulation ТР ТС 005/2011 enabled 
to detect phthalates in the packages of bottled water, able to migrate into the bottled water. The 
results justify the necessity to monitor phthalates in bottled water. 
Keywords: bisphenol А, phthalates, bottled water, drinking water, polyethyleneterephthalate, 
polycarbonate.
Actuality
Recently for portable water supply bottled water is increasingly used. For packaging 
water, food products, drugs etc. plastics is commonly used. For production polycarbonate 
packaging plastics bisphenol А (BPА) and phthalates [1; 2] are used.
BPA are regularly detected in urine, in blood, in milk in other biological samples [3–5]. 
BPA effect results to such consequences for human health as diabetes, obesity and car-
diovascular diseases (coronary heart disease, hypertensive disease, coagulation failure), 
cancer diseases (breast cancer, prostatic and thyroid cancer), pathology of nerve (neuro-
genesis disorder, apoplexies, Parkinson’s diseas) and reproductive (sex cycle disorder, en-
dometriosis, changes in lactiferous gland, in prostate) systems. Performed investigations 
demonstrated, that higher levels of BPA in urine during period of pregnancy increase pos-
sibility of fetal weight decrease. It was proved, that BPA may penetrate through the human 
placenta and, therefore may present a risk for fetal development. BPA impact may be one 
of the reasons of chronic respiratory diseases (asthma), and also delay of development and 
psychical disorders (anxiety, depression, hyperactivity, aggression) [6; 7].
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It was determined [8; 9], that low doze BPA impact in embryonic period influences 
the cell of prostate, increasing proneness towards pre-cancer lesion of these organ and 
hormonal disorders in adults. There are exists an opinion, that prostate cells are suscep-
tive to BPA impacts at embryonic period. BPA impacts induces DNA adducts at this 
pathology. 
BPA may disturb reproduction processes in women, suppressing DNA methylation. 
Neonatal BPA impact on mouses results to ingibiting of oocytes maturation [10–12].
BPA (even at low dozes) may propagate through placenta, accumulates in fetus and 
exert negative impact at duration of the whole antepartum period. On of the adverse con-
sequences for fetus health is decrease of mass body centile at birth. 
Besides, BPA impact across pregnancy may lead to increase of accidental abortions 
number, abnormal pregnancy duration, increase of male genital organs abnormalities and 
childhood obesity [6; 13]. 
At present time it was discovered, that those persons, who were subjected to BPA 
impact, increases the risk of coronary artery atherosclerosis development. So, in patients 
with severe stenosis of coronary arteries increase of BPA concentration in urine was de-
tected as compared with persons without atherosclerosis. It was found that more suscep-
tible to cardiovascular diseases were carriers of some genetic polymorphisms, associated 
with decrease cells response to oxidative stress. It is necessary to point out that one of 
the possible molecular mechanism of bisphenol A action may be its influence namely on 
oxidative stress [14–16].
Phtalates preset a wide spectrum of chemical compounds. After absorption phtalates 
are rapidly metabolized and removed through urinary system and gastrointestinal tract. 
Biological half-life of different metabolite phtalates constitutes approximately from 3 to 
18 hours [17–19].
There is a certain information, that phtalates impact may cause multiple negative side 
effects for human health, including endocrine disorders, neural development disorders, 
disorders of cardiovascular and reproductive systems. Phalates may provide impact by 
means of different mechanisms, from nuclear hormone receptors (including estrogen re-
ceptors, androgen receptors) to membrane and nonsteroidal receptors and other mecha-
nisms [20]. 
It is well known, that perinatal phtalates impact may cause reproductive abnormali-
ties, including defects of epididymis development, deferent duct, seminal vesicles, pros-
tate, external genitalia (hypospadias), cryptorchidism, testis trauma, decrease of anogeni-
tal distance and changes of sexual differentiation. Besides, increasing number of epide-
miological studies demonstrated the phtalates impact on human may cause numerous 
side effects, such as increase of respiratory and allergic diseases in children, depression 
of lungs function and depression in elderly person, high risk of liver function decrease 
and cardiometabolic disorders in men, neurodevelopment slowing in infants, and also 
increased risk of overweight and obesity [21–24].
Phtalates possess sufficiently confirmed antiandrogenic activity in investigations per-
formed at rodents, resulting in circulating testosterone decreasing. All the biomonitoring 
studies of human confirmes the opinion that phtalates impact impairs sperm quality (de-
creasing spermatozoids mobility and sperm volume, aneuploidy of spermatozoids) and 
decrease the level of reproductive hormones, causing the problem with fertility in men at 
reproductive age [25]. Also phtalates impact on men results to development of phtalates 
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syndrome. Anogenital distance (AGD) together with hypospadias, cryptorchidism and 
epididymidis diseases, deferent duct, seminal vesicles and prostate gland constitute phta-
late syndrome. And phtalate impact on women health results to endometriosis, leiomyo-
ma, breast cancer and diabetes of 2nd type [26; 27]. Phtales are associated with increased 
risk of premature birth — one of the main reasons of neonatal mortality [28]. 
With regard to phtalates impact on cardiovascular system, there exist a little evidence 
. In children and pregnant women, phtalates impact is accompanied by increase of arte-
rial pressure. It was discovered that the main DEHP metabolite exerts cardiotoxic action. 
Epidemiological studies permit to reveal correlations, but not the casual relations between 
the impact and the disease. Nevertheless, that sphere requires further inquiry, bacause 
the data indicates increased risk of cardiovascular diseases resulted from phtalates impact 
[29–31].
The purpose of investigation performance is to study characteristics and analysis of 
package samples made of polymer material, contacting with portable water.
Material and methods
As a research objects, seven samples of bottles made from polyethyleneterephthalate 
(PET) and from polycarbonate (PC), manufactured in Russian Federation by the following 
six manufacturers: LLC “Formplact”, LLC “Aquantic”, LLC “Alfatechform”, LLC “Plast-М”. 
Presented products are available in trading network of Saint-Petersburg. 
Characteristics of test products presented in Table 1.
Table 1. Characteristics of test products samples
№ 
Item Description of bottled water package sample
1 Sample of portable water package (PET bottle — 6.0 l); package manufacturer LLC “Formplast”
2 Sample of portable water package (PET bottle (disposable) — 19.0 l); package manufacturer LLC 
“Aquatic”
3 Sample of portable water package (PET bottle (reusable)  — 19.0  l); package manufacturer LLC 
“Aquatic”
4 Sample of portable water package (PET bottle (with water) — 6.0 l); package manufacturer LLC 
“Alfatechfarm”
5 Sample of portable water package (PET bottle with handle — 19.0 l); package manufacturer LLC 
“Plast-M”
6 Sample of portable water package (PET bottle green — 19.0 l); package manufacturer LLC “Plast-M”
7 Sample of portable water package (PET bottle green — 19.0 l); package manufacturer LLC “Plast-M”
Sanitary-and-hygienic tests of polymer (package) materials were performed by 
Chemical-analytical centre «Arbitrag» Federal state unitary enterprise “VNIIM named 
after D. I. Mendeleev” Detection of phtalates  — di(2-ethylhexyl) phtalate, di(isobutyl)
phtalate, di(n-butyle)phtalate was carried out in polymeric material, which was used for 
packaging portable water. 
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Results of investigation
All the measurements were performed in accord with Technical regulation of Cus-
toms union ТR ТS 005/2011 “About package safety” and “Instruction on sanitary-chemi-
cal products tests, manufactured from polymer and other synthetic materials, designed to 
contact with food products”. 
Results of packages and bottled water tests after 30 days of storage in plastic package 
presented in tables 2 and 3.
Table 2. Results of polymeric (packaging) materials testing (mg/kg)
nurses
Sample number




























































Table 3. Results of bottled water testing after 30 days of storage in plastic package (mg/l)
Samples



















1 18 2.6 6.4 19 2.6 6.5
2 14.5 2.6 2.6 13 2.6 7.2
3 8.55 2.6 4.05 13 2.6 3.5
4 16 2.6 9.75 20.5 2.6 6.35
5 14.5 2.6 6.1 16.5 2.6 4.1
6 71 2.6 19.15 24.5 2.6 10.1
7 13 2.6 10.05 54.5 4.3 15
Average value 22.22 2.6 8.3 23 2.84 7.54
Median value 14.5 2.6 6.4 19 2.6 6.5
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Phtalates and biphenol А are hazardous for human health in microquantities, their 
content in portable water are rated at level 8000 microgram/l1. Phalates possess ability to 
migrate from package material into aqueous medium and they provide monodirectional 
action with bisphenol A and may enter into human organism not only with portacle water, 
but also with foodstuff packaged into plastic. 
Conclusions
Results of performed investigations enable to justify the necessity of monitoring pha-
lates in bottled portable water due to phalates ability to migrate from plastic package into 
aqueous medium and ability of intermedium penetration into human organism in con-
junction with bisphenol A. 
Total amount of toxic substances penetrated from plastic packages may exceed refer-
ence concentration and produce considerable risk to public health.
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